Acute myeloid leukemia drugmaker closes $14.2M, focuses on personalized medicine
Tolero Pharmaceuticals, a Salt Lake City, Utah drug developer, has set its sights on ramping up the commercialization and development efforts of its acute myeloid leukemia treatment, which will enter Phase 3 trial sometime next year. The company’s fresh off of closing a Series B round of $14.2 million, though the initial aim for the […]